National Health Investors - NHI Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $61.25
  • Forecasted Upside: -6.27%
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$65.35
▲ +0.72 (1.11%)

This chart shows the closing price for NHI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New National Health Investors Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NHI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NHI

Analyst Price Target is $61.25
▼ -6.27% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $61.25, with a high forecast of $69.00 and a low forecast of $52.00. The average price target represents a -6.27% upside from the last price of $65.35.

This chart shows the closing price for NHI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 8 investment analysts is to moderate buy stock in National Health Investors. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/21/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/21/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/19/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/17/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/16/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/15/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/14/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/13/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/30/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$63.00 ➝ $69.00Low
4/4/2024Truist FinancialBoost TargetHold ➝ Hold$55.00 ➝ $58.00Low
3/18/2024WedbushBoost TargetOutperform ➝ Outperform$64.00 ➝ $66.00Low
3/12/2024BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$67.00Low
2/26/2024WedbushUpgradeNeutral ➝ Outperform$57.00 ➝ $64.00Low
2/26/2024Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$55.00 ➝ $63.00Low
1/30/2024Deutsche Bank AktiengesellschaftInitiated CoverageBuy$69.00Low
11/28/2023Stifel NicolausReiterated RatingHold ➝ Hold$55.00Low
11/27/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$54.00 ➝ $55.00Low
10/3/2023WedbushInitiated CoverageNeutral$54.00Low
9/28/2023Berenberg BankInitiated CoverageHold$54.00Low
9/20/2023Jefferies Financial GroupInitiated CoverageHold$52.00Low
6/22/2023Truist FinancialBoost Target$56.00 ➝ $57.00Low
4/19/2023Wells Fargo & CompanyInitiated CoverageEqual Weight$52.00Low
3/29/2023Credit Suisse GroupLower TargetNeutral$55.00 ➝ $50.00Low
12/9/2022Credit Suisse GroupUpgradeUnderperform ➝ Neutral$47.00 ➝ $58.00Low
11/4/2022Credit Suisse GroupLower Target$47.00Low
9/26/2022Truist FinancialLower TargetHold$64.00 ➝ $61.00Low
6/22/2022Credit Suisse GroupInitiated CoverageUnderperformLow
6/21/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$62.00Low
6/3/2022Capital One FinancialInitiated CoverageOverweight ➝ Overweight$64.00Medium
4/19/2022BMO Capital MarketsLower TargetOutperform$63.00 ➝ $61.00Medium
2/1/2022Credit Suisse GroupInitiated CoverageUnderperform$51.00Medium
1/7/2022BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$68.00High
11/9/2021Capital One FinancialUpgradeEqual Weight ➝ OverweightHigh
9/23/2021Truist FinancialLower TargetHold$71.00 ➝ $64.00Low
7/23/2021Wells Fargo & CompanyLower TargetEqual Weight$74.00 ➝ $72.00Low
6/18/2021BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$71.00High
4/5/2021Wells Fargo & CompanyBoost TargetHold ➝ Equal Weight$66.00 ➝ $74.00Low
3/30/2021Capital One FinancialDowngradeOverweight ➝ Equal Weight$77.00Low
3/23/2021Truist FinancialBoost Target$69.00 ➝ $74.00Low
1/13/2021MizuhoDowngradeNeutral ➝ Underperform$56.00 ➝ $55.00Medium
1/7/2021BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$68.00Low
12/14/2020KeyCorpUpgradeUnderweight ➝ Sector WeightMedium
12/2/2020Berenberg BankDowngradeBuy ➝ HoldLow
9/1/2020Stifel NicolausReiterated RatingHold$63.00High
6/24/2020SunTrust BanksBoost TargetHold$61.00 ➝ $64.00Low
6/17/2020Wells Fargo & CompanyBoost TargetEqual Weight$54.00 ➝ $66.00High
6/8/2020JMP SecuritiesInitiated CoverageMarket PerformHigh
5/22/2020MizuhoDowngradeBuy ➝ Neutral$60.00 ➝ $55.00Medium
5/14/2020KeyCorpLower TargetUnderweight$43.00 ➝ $40.00High
4/23/2020SunTrust BanksLower TargetHold$77.00 ➝ $61.00Low
4/21/2020KeyCorpLower TargetUnderweight$65.00 ➝ $43.00Medium
3/26/2020Wells Fargo & CompanyLower TargetEqual Weight$82.00 ➝ $51.00High
2/5/2020Berenberg BankInitiated CoverageBuy$94.00Medium
1/7/2020BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$74.00 ➝ $82.00Low
12/20/2019MizuhoReiterated RatingBuy$95.00High
(Data available from 6/13/2019 forward)

News Sentiment Rating

1.21 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/16/2023
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/16/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/15/2024
  • 5 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/14/2024
  • 17 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
3/15/2024
  • 2 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/14/2024
  • 5 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/14/2024
  • 10 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2024

Current Sentiment

  • 10 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
National Health Investors logo
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More

Today's Range

Now: $65.35
Low: $65.27
High: $66.35

50 Day Range

MA: $63.63
Low: $58.35
High: $67.34

52 Week Range

Now: $65.35
Low: $48.51
High: $68.14

Volume

151,236 shs

Average Volume

161,706 shs

Market Capitalization

$2.84 billion

P/E Ratio

21.43

Dividend Yield

5.49%

Beta

1

Frequently Asked Questions

What sell-side analysts currently cover shares of National Health Investors?

The following sell-side analysts have issued stock ratings on National Health Investors in the last twelve months: Berenberg Bank, BMO Capital Markets, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Stifel Nicolaus, StockNews.com, TheStreet, Truist Financial Co., Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for NHI.

What is the current price target for National Health Investors?

8 Wall Street analysts have set twelve-month price targets for National Health Investors in the last year. Their average twelve-month price target is $61.25, suggesting a possible downside of 6.3%. Wells Fargo & Company has the highest price target set, predicting NHI will reach $69.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $52.00 for National Health Investors in the next year.
View the latest price targets for NHI.

What is the current consensus analyst rating for National Health Investors?

National Health Investors currently has 4 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for NHI.

What other companies compete with National Health Investors?

How do I contact National Health Investors' investor relations team?

National Health Investors' physical mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust's listed phone number is (615) 890-9100 and its investor relations email address is [email protected]. The official website for National Health Investors is www.nhireit.com. Learn More about contacing National Health Investors investor relations.